Plasmid Acquisition Alters Vancomycin Susceptibility in Clostridioides difficile

Area of Science:

• Microbiology
• Infectious Diseases
• Genetics

Background:

• Clostridioides difficile infections (CDI) are increasing, with rising resistance to current treatments like vancomycin.
• The changing biology of C. difficile may contribute to treatment evasion and recurring infections.

Purpose of the Study:

• To investigate a potential plasmid-mediated mechanism for decreased vancomycin susceptibility in C. difficile.
• To explore the role of plasmid transfer in vancomycin treatment failure.

Main Methods:

• Identification of a transferable plasmid in a vancomycin-resistant C. difficile strain.
• In vitro experiments transferring the plasmid to a vancomycin-susceptible strain.
• Evaluation of disease severity in a humanized mouse model post-plasmid transfer.

Main Results:

• A broad host range transferable plasmid was identified in a C. difficile strain with poor vancomycin response.
• Plasmid transfer decreased vancomycin susceptibility in vitro.
• Transferred plasmid led to more severe disease in a humanized mouse model.

Conclusions:

• Plasmid acquisition in the gastrointestinal tract is a potential mechanism for vancomycin treatment failure in CDI.
• Further research is needed to elucidate the specific plasmid genes and mechanisms affecting vancomycin susceptibility.